Latest Breaking News On - Amgen imdelltra - Page 1 : vimarsana.com

Amgen's interchangeable Soliris biosimilar Bkemv approved by FDA for rare blood disorders

Biotech Stocks Facing FDA Decision In June 2024

THOUSAND OAKS (dpa-AFX) - Every year, the month of June is observed as the Alzheimer's and Brain Awareness Month, a time dedicated to raising awareness and fostering conversations about Alzheimer's

Amgen's Imdelltra granted FDA accelerated approval to treat small cell lung cancer

More than 234,000 new cases of lung cancer are expected to be diagnosed in the US this year

FDA approves Amgen's treatment for most deadly form of lung cancer

The agency cleared the drug, called Imdelltra, as a second or later-line treatment for adults with advanced small-cell lung cancer.

FDA approves Amgen T-cell engager for small cell lung cancer